MediPharm Lab News

Leading Independent Proxy Advisor ISS Recommends that Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees; REJECTS Apollo’s Arguments and Director Slate ISS concludes that Apollo “has not presented a compelling case for change”

MediPharm Labs Responds to Fabricated Allegations from Dissident Shareholder

MediPharm Labs Board Issues Letter to Shareholders in Response to Inadequate Dissident Plan

MediPharm Labs Begins Production of First Order for International Expansion of Novel Cannabis Metered Dose Portfolio in the EU and United Kingdom Under Blackpoint Sales and Distribution Agreement